These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 6279300

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Stimulation by carcinogens and promoters of prostaglandin production by dog kidney (MDCK) cells in culture.
    Levine L, Ohuchi K.
    Cancer Res; 1978 Nov; 38(11 Pt 2):4142-6. PubMed ID: 698958
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Differential effects of complete and second-stage tumour promoters in normal but not transformed human and mouse keratinocytes.
    Parkinson EK, Pera MF, Emmerson A, Gorman PA.
    Carcinogenesis; 1984 Aug; 5(8):1071-7. PubMed ID: 6204790
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Diacylglycerols and mezerein activate neutrophils by a phorbol myristate acetate-like mechanism.
    O'Flaherty JT, Schmitt JD, Wykle RL, Redman JF, McCall CE.
    J Cell Physiol; 1985 Nov; 125(2):192-9. PubMed ID: 3932370
    [Abstract] [Full Text] [Related]

  • 30. Relationship between mezerein-mediated biological responses and phorbol ester receptor occupancy.
    Jaken S, Shupnik MA, Blumberg PM, Tashjian AH.
    Cancer Res; 1983 Jan; 43(1):11-4. PubMed ID: 6600158
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Nature of the epidermal hyperplasia produced by mezerein, a weak tumor promoter, in initiated skin of mice.
    Argyris TS.
    Cancer Res; 1983 Apr; 43(4):1768-73. PubMed ID: 6403228
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Current aspects of oxygen metabolism, II. Function of free radicals].
    Solal-Celigny P, Laviolette M.
    Union Med Can; 1982 Mar; 111(3):223-8. PubMed ID: 6281955
    [No Abstract] [Full Text] [Related]

  • 36. Tumour-promoting diterpene esters prevent macrophage activation.
    Keller R, Keist R, Hecker E.
    Br J Cancer; 1982 Jan; 45(1):144-6. PubMed ID: 7059458
    [No Abstract] [Full Text] [Related]

  • 37. PRomotion of smooth surface tumorigenicity by phorbol myristate acetate in Balb/3T3 cells and Balb/3T3 T proadipocytes.
    Scott RE, Boone CW.
    J Natl Cancer Inst; 1981 Apr; 66(4):733-6. PubMed ID: 6939919
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Phorbol diacetate inhibits superoxide anion radical production and tumor promotion by mezerein.
    Czerniecki B, Gad SC, Reilly C, Smith AC, Witz G.
    Carcinogenesis; 1986 Oct; 7(10):1637-41. PubMed ID: 3019585
    [Abstract] [Full Text] [Related]

  • 40. Reversible inhibition of cell differentiation by phorbol esters as a possible mechanism of the promotion step in chemical carcinogenesis.
    Yamasaki H.
    IARC Sci Publ; 1980 Oct; (27):91-111. PubMed ID: 7002785
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.